心血管

订阅

MedSci主页 / 所有栏目 / 心血管

话题：3岁患儿输血70余次感染艾滋病毒，医院和血液中心谁的责任？

2024-04-03 网络 网络 发表于上海

艾滋病毒话题输血感染
关注

近日，一起3岁患儿在接受输血后感染艾滋病毒的悲剧引发了广泛关注。

近日，一起3岁患儿在接受输血后感染艾滋病毒的悲剧引发了广泛关注。

因诊断“重度再生障碍性贫血”，给予输血及免疫抑制剂等对症治疗，先后在医院6次，输血70余次，在此期间HIV抗体检测均为阴性。

但是就在该患者在第7次输血治疗时，住院期间被临床检验中心及省疾控中心检测确认其感染艾滋病病毒。这一消息无疑给患儿的家庭带来了巨大的打击和无尽的悲痛。

为什么会感染了艾滋病毒呢？是医院的疏忽，还是血液中心提供了带有病毒的血液?又或者双方都存在疏忽？这些问题都值得我们深入探讨。你都知道哪些输血小知识，也欢迎评论一起交流学习。

在此小编诚挚的邀请大家积极参与本期话题讨论，插入话题关键词#输血感染#，发表自己的观点和输血小知识。让我们一起为医疗安全贡献智慧和力量！

本期话题给大家准备的了积分和养生姜茶，凡参与评论的均可获取10积分，同时评论随机选出2名插入关键词#输血感染#的优质评论费送出姜茶礼盒。动动手指快来发布评论领取礼品吧！

（上期话题中奖通知已公布在评论区)

有关医师节分享#医生的一天#话题中奖名单：ms2000000147841561、Joyrong、ms5000000552008919、以上三位老师可添加助教领取礼品啦！

有关#春季过敏#话题中间名单：12be8a33m87暂无昵称 、**p126、yusinxy、以上三位老师可添加助教领取礼品啦！

（扫描领礼品）

评论区 (43)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2256531, encodeId=1a40225653102, content=引起重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83098321849, createdName=ms9000001546471374, createdTime=Tue Mar 18 00:35:38 CST 2025, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252280, encodeId=569d22522800d, content=可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220814/be36b1918b4c4eeba48ae6c167571ce9/3bd4e17f256d4fdba54abc66bb0f616c.jpg, createdBy=a4042044999, createdName=jiangwei200908, createdTime=Mon Feb 17 08:51:28 CST 2025, time=2025-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248460, encodeId=20082248460d9, content=追责堵漏防再发生！给岀解决方案, beContent=null, objectType=article, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220616/51508ed9a34741d2a61370b3293bb4f7/7f66d05e01f147f381a95f877e2de076.jpg, createdBy=58a75313391, createdName=13895086385H一, createdTime=Fri Jan 17 10:02:18 CST 2025, time=2025-01-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244256, encodeId=bde8224425600, content=谁的责任，这怎么分啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=美其美, createdTime=Sun Dec 22 06:41:40 CST 2024, time=2024-12-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243556, encodeId=ad022243556f7, content=谁的责任？不？, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Thu Dec 19 17:53:49 CST 2024, time=2024-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2242646, encodeId=8c85224264644, content=后果已经造成，现在要做的就是尽快决定解决方案。, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231c9560749, createdName=ms7000002062633164, createdTime=Sun Dec 15 16:09:57 CST 2024, time=2024-12-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233677, encodeId=941822336e759, content=我认为主要责任在血液中心, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e4d9506295, createdName=诗合晴岚, createdTime=Mon Oct 28 14:53:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232588, encodeId=2057223258805, content=哪里出的问题？, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Wed Oct 23 08:25:10 CST 2024, time=2024-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232451, encodeId=e40722324512b, content=需要倒查, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 14:25:26 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232323, encodeId=1d3022323231a, content=仔细查一下是谁的责任, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 07:38:41 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省)]
    昨天 ms9000001546471374 来自四川省

    引起重视

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2256531, encodeId=1a40225653102, content=引起重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83098321849, createdName=ms9000001546471374, createdTime=Tue Mar 18 00:35:38 CST 2025, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252280, encodeId=569d22522800d, content=可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220814/be36b1918b4c4eeba48ae6c167571ce9/3bd4e17f256d4fdba54abc66bb0f616c.jpg, createdBy=a4042044999, createdName=jiangwei200908, createdTime=Mon Feb 17 08:51:28 CST 2025, time=2025-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248460, encodeId=20082248460d9, content=追责堵漏防再发生！给岀解决方案, beContent=null, objectType=article, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220616/51508ed9a34741d2a61370b3293bb4f7/7f66d05e01f147f381a95f877e2de076.jpg, createdBy=58a75313391, createdName=13895086385H一, createdTime=Fri Jan 17 10:02:18 CST 2025, time=2025-01-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244256, encodeId=bde8224425600, content=谁的责任，这怎么分啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=美其美, createdTime=Sun Dec 22 06:41:40 CST 2024, time=2024-12-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243556, encodeId=ad022243556f7, content=谁的责任？不？, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Thu Dec 19 17:53:49 CST 2024, time=2024-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2242646, encodeId=8c85224264644, content=后果已经造成，现在要做的就是尽快决定解决方案。, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231c9560749, createdName=ms7000002062633164, createdTime=Sun Dec 15 16:09:57 CST 2024, time=2024-12-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233677, encodeId=941822336e759, content=我认为主要责任在血液中心, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e4d9506295, createdName=诗合晴岚, createdTime=Mon Oct 28 14:53:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232588, encodeId=2057223258805, content=哪里出的问题？, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Wed Oct 23 08:25:10 CST 2024, time=2024-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232451, encodeId=e40722324512b, content=需要倒查, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 14:25:26 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232323, encodeId=1d3022323231a, content=仔细查一下是谁的责任, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 07:38:41 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省)]
    2025-02-17 jiangwei200908 来自上海

    可怕

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2256531, encodeId=1a40225653102, content=引起重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83098321849, createdName=ms9000001546471374, createdTime=Tue Mar 18 00:35:38 CST 2025, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252280, encodeId=569d22522800d, content=可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220814/be36b1918b4c4eeba48ae6c167571ce9/3bd4e17f256d4fdba54abc66bb0f616c.jpg, createdBy=a4042044999, createdName=jiangwei200908, createdTime=Mon Feb 17 08:51:28 CST 2025, time=2025-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248460, encodeId=20082248460d9, content=追责堵漏防再发生！给岀解决方案, beContent=null, objectType=article, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220616/51508ed9a34741d2a61370b3293bb4f7/7f66d05e01f147f381a95f877e2de076.jpg, createdBy=58a75313391, createdName=13895086385H一, createdTime=Fri Jan 17 10:02:18 CST 2025, time=2025-01-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244256, encodeId=bde8224425600, content=谁的责任，这怎么分啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=美其美, createdTime=Sun Dec 22 06:41:40 CST 2024, time=2024-12-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243556, encodeId=ad022243556f7, content=谁的责任？不？, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Thu Dec 19 17:53:49 CST 2024, time=2024-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2242646, encodeId=8c85224264644, content=后果已经造成，现在要做的就是尽快决定解决方案。, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231c9560749, createdName=ms7000002062633164, createdTime=Sun Dec 15 16:09:57 CST 2024, time=2024-12-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233677, encodeId=941822336e759, content=我认为主要责任在血液中心, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e4d9506295, createdName=诗合晴岚, createdTime=Mon Oct 28 14:53:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232588, encodeId=2057223258805, content=哪里出的问题？, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Wed Oct 23 08:25:10 CST 2024, time=2024-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232451, encodeId=e40722324512b, content=需要倒查, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 14:25:26 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232323, encodeId=1d3022323231a, content=仔细查一下是谁的责任, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 07:38:41 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省)]
    2025-01-17 13895086385H一 来自上海

    追责堵漏防再发生！给岀解决方案

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2256531, encodeId=1a40225653102, content=引起重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83098321849, createdName=ms9000001546471374, createdTime=Tue Mar 18 00:35:38 CST 2025, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252280, encodeId=569d22522800d, content=可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220814/be36b1918b4c4eeba48ae6c167571ce9/3bd4e17f256d4fdba54abc66bb0f616c.jpg, createdBy=a4042044999, createdName=jiangwei200908, createdTime=Mon Feb 17 08:51:28 CST 2025, time=2025-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248460, encodeId=20082248460d9, content=追责堵漏防再发生！给岀解决方案, beContent=null, objectType=article, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220616/51508ed9a34741d2a61370b3293bb4f7/7f66d05e01f147f381a95f877e2de076.jpg, createdBy=58a75313391, createdName=13895086385H一, createdTime=Fri Jan 17 10:02:18 CST 2025, time=2025-01-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244256, encodeId=bde8224425600, content=谁的责任，这怎么分啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=美其美, createdTime=Sun Dec 22 06:41:40 CST 2024, time=2024-12-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243556, encodeId=ad022243556f7, content=谁的责任？不？, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Thu Dec 19 17:53:49 CST 2024, time=2024-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2242646, encodeId=8c85224264644, content=后果已经造成，现在要做的就是尽快决定解决方案。, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231c9560749, createdName=ms7000002062633164, createdTime=Sun Dec 15 16:09:57 CST 2024, time=2024-12-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233677, encodeId=941822336e759, content=我认为主要责任在血液中心, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e4d9506295, createdName=诗合晴岚, createdTime=Mon Oct 28 14:53:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232588, encodeId=2057223258805, content=哪里出的问题？, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Wed Oct 23 08:25:10 CST 2024, time=2024-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232451, encodeId=e40722324512b, content=需要倒查, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 14:25:26 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232323, encodeId=1d3022323231a, content=仔细查一下是谁的责任, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 07:38:41 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省)]
    2024-12-22 美其美 来自江苏省

    谁的责任，这怎么分啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2256531, encodeId=1a40225653102, content=引起重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83098321849, createdName=ms9000001546471374, createdTime=Tue Mar 18 00:35:38 CST 2025, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252280, encodeId=569d22522800d, content=可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220814/be36b1918b4c4eeba48ae6c167571ce9/3bd4e17f256d4fdba54abc66bb0f616c.jpg, createdBy=a4042044999, createdName=jiangwei200908, createdTime=Mon Feb 17 08:51:28 CST 2025, time=2025-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248460, encodeId=20082248460d9, content=追责堵漏防再发生！给岀解决方案, beContent=null, objectType=article, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220616/51508ed9a34741d2a61370b3293bb4f7/7f66d05e01f147f381a95f877e2de076.jpg, createdBy=58a75313391, createdName=13895086385H一, createdTime=Fri Jan 17 10:02:18 CST 2025, time=2025-01-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244256, encodeId=bde8224425600, content=谁的责任，这怎么分啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=美其美, createdTime=Sun Dec 22 06:41:40 CST 2024, time=2024-12-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243556, encodeId=ad022243556f7, content=谁的责任？不？, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Thu Dec 19 17:53:49 CST 2024, time=2024-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2242646, encodeId=8c85224264644, content=后果已经造成，现在要做的就是尽快决定解决方案。, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231c9560749, createdName=ms7000002062633164, createdTime=Sun Dec 15 16:09:57 CST 2024, time=2024-12-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233677, encodeId=941822336e759, content=我认为主要责任在血液中心, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e4d9506295, createdName=诗合晴岚, createdTime=Mon Oct 28 14:53:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232588, encodeId=2057223258805, content=哪里出的问题？, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Wed Oct 23 08:25:10 CST 2024, time=2024-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232451, encodeId=e40722324512b, content=需要倒查, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 14:25:26 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232323, encodeId=1d3022323231a, content=仔细查一下是谁的责任, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 07:38:41 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省)]
    2024-12-19 13de4a3em68暂无昵称 来自浙江省

    谁的责任？不？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2256531, encodeId=1a40225653102, content=引起重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83098321849, createdName=ms9000001546471374, createdTime=Tue Mar 18 00:35:38 CST 2025, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252280, encodeId=569d22522800d, content=可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220814/be36b1918b4c4eeba48ae6c167571ce9/3bd4e17f256d4fdba54abc66bb0f616c.jpg, createdBy=a4042044999, createdName=jiangwei200908, createdTime=Mon Feb 17 08:51:28 CST 2025, time=2025-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248460, encodeId=20082248460d9, content=追责堵漏防再发生！给岀解决方案, beContent=null, objectType=article, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220616/51508ed9a34741d2a61370b3293bb4f7/7f66d05e01f147f381a95f877e2de076.jpg, createdBy=58a75313391, createdName=13895086385H一, createdTime=Fri Jan 17 10:02:18 CST 2025, time=2025-01-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244256, encodeId=bde8224425600, content=谁的责任，这怎么分啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=美其美, createdTime=Sun Dec 22 06:41:40 CST 2024, time=2024-12-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243556, encodeId=ad022243556f7, content=谁的责任？不？, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Thu Dec 19 17:53:49 CST 2024, time=2024-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2242646, encodeId=8c85224264644, content=后果已经造成，现在要做的就是尽快决定解决方案。, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231c9560749, createdName=ms7000002062633164, createdTime=Sun Dec 15 16:09:57 CST 2024, time=2024-12-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233677, encodeId=941822336e759, content=我认为主要责任在血液中心, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e4d9506295, createdName=诗合晴岚, createdTime=Mon Oct 28 14:53:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232588, encodeId=2057223258805, content=哪里出的问题？, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Wed Oct 23 08:25:10 CST 2024, time=2024-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232451, encodeId=e40722324512b, content=需要倒查, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 14:25:26 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232323, encodeId=1d3022323231a, content=仔细查一下是谁的责任, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 07:38:41 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省)]
    2024-12-15 ms7000002062633164 来自四川省

    后果已经造成，现在要做的就是尽快决定解决方案。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2256531, encodeId=1a40225653102, content=引起重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83098321849, createdName=ms9000001546471374, createdTime=Tue Mar 18 00:35:38 CST 2025, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252280, encodeId=569d22522800d, content=可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220814/be36b1918b4c4eeba48ae6c167571ce9/3bd4e17f256d4fdba54abc66bb0f616c.jpg, createdBy=a4042044999, createdName=jiangwei200908, createdTime=Mon Feb 17 08:51:28 CST 2025, time=2025-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248460, encodeId=20082248460d9, content=追责堵漏防再发生！给岀解决方案, beContent=null, objectType=article, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220616/51508ed9a34741d2a61370b3293bb4f7/7f66d05e01f147f381a95f877e2de076.jpg, createdBy=58a75313391, createdName=13895086385H一, createdTime=Fri Jan 17 10:02:18 CST 2025, time=2025-01-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244256, encodeId=bde8224425600, content=谁的责任，这怎么分啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=美其美, createdTime=Sun Dec 22 06:41:40 CST 2024, time=2024-12-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243556, encodeId=ad022243556f7, content=谁的责任？不？, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Thu Dec 19 17:53:49 CST 2024, time=2024-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2242646, encodeId=8c85224264644, content=后果已经造成，现在要做的就是尽快决定解决方案。, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231c9560749, createdName=ms7000002062633164, createdTime=Sun Dec 15 16:09:57 CST 2024, time=2024-12-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233677, encodeId=941822336e759, content=我认为主要责任在血液中心, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e4d9506295, createdName=诗合晴岚, createdTime=Mon Oct 28 14:53:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232588, encodeId=2057223258805, content=哪里出的问题？, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Wed Oct 23 08:25:10 CST 2024, time=2024-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232451, encodeId=e40722324512b, content=需要倒查, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 14:25:26 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232323, encodeId=1d3022323231a, content=仔细查一下是谁的责任, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 07:38:41 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省)]
    2024-10-28 诗合晴岚 来自北京

    我认为主要责任在血液中心

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2256531, encodeId=1a40225653102, content=引起重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83098321849, createdName=ms9000001546471374, createdTime=Tue Mar 18 00:35:38 CST 2025, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252280, encodeId=569d22522800d, content=可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220814/be36b1918b4c4eeba48ae6c167571ce9/3bd4e17f256d4fdba54abc66bb0f616c.jpg, createdBy=a4042044999, createdName=jiangwei200908, createdTime=Mon Feb 17 08:51:28 CST 2025, time=2025-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248460, encodeId=20082248460d9, content=追责堵漏防再发生！给岀解决方案, beContent=null, objectType=article, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220616/51508ed9a34741d2a61370b3293bb4f7/7f66d05e01f147f381a95f877e2de076.jpg, createdBy=58a75313391, createdName=13895086385H一, createdTime=Fri Jan 17 10:02:18 CST 2025, time=2025-01-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244256, encodeId=bde8224425600, content=谁的责任，这怎么分啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=美其美, createdTime=Sun Dec 22 06:41:40 CST 2024, time=2024-12-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243556, encodeId=ad022243556f7, content=谁的责任？不？, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Thu Dec 19 17:53:49 CST 2024, time=2024-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2242646, encodeId=8c85224264644, content=后果已经造成，现在要做的就是尽快决定解决方案。, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231c9560749, createdName=ms7000002062633164, createdTime=Sun Dec 15 16:09:57 CST 2024, time=2024-12-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233677, encodeId=941822336e759, content=我认为主要责任在血液中心, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e4d9506295, createdName=诗合晴岚, createdTime=Mon Oct 28 14:53:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232588, encodeId=2057223258805, content=哪里出的问题？, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Wed Oct 23 08:25:10 CST 2024, time=2024-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232451, encodeId=e40722324512b, content=需要倒查, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 14:25:26 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232323, encodeId=1d3022323231a, content=仔细查一下是谁的责任, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 07:38:41 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省)]
    2024-10-23 13de4a3em68暂无昵称 来自浙江省

    哪里出的问题？

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2256531, encodeId=1a40225653102, content=引起重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83098321849, createdName=ms9000001546471374, createdTime=Tue Mar 18 00:35:38 CST 2025, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252280, encodeId=569d22522800d, content=可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220814/be36b1918b4c4eeba48ae6c167571ce9/3bd4e17f256d4fdba54abc66bb0f616c.jpg, createdBy=a4042044999, createdName=jiangwei200908, createdTime=Mon Feb 17 08:51:28 CST 2025, time=2025-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248460, encodeId=20082248460d9, content=追责堵漏防再发生！给岀解决方案, beContent=null, objectType=article, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220616/51508ed9a34741d2a61370b3293bb4f7/7f66d05e01f147f381a95f877e2de076.jpg, createdBy=58a75313391, createdName=13895086385H一, createdTime=Fri Jan 17 10:02:18 CST 2025, time=2025-01-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244256, encodeId=bde8224425600, content=谁的责任，这怎么分啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=美其美, createdTime=Sun Dec 22 06:41:40 CST 2024, time=2024-12-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243556, encodeId=ad022243556f7, content=谁的责任？不？, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Thu Dec 19 17:53:49 CST 2024, time=2024-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2242646, encodeId=8c85224264644, content=后果已经造成，现在要做的就是尽快决定解决方案。, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231c9560749, createdName=ms7000002062633164, createdTime=Sun Dec 15 16:09:57 CST 2024, time=2024-12-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233677, encodeId=941822336e759, content=我认为主要责任在血液中心, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e4d9506295, createdName=诗合晴岚, createdTime=Mon Oct 28 14:53:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232588, encodeId=2057223258805, content=哪里出的问题？, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Wed Oct 23 08:25:10 CST 2024, time=2024-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232451, encodeId=e40722324512b, content=需要倒查, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 14:25:26 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232323, encodeId=1d3022323231a, content=仔细查一下是谁的责任, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 07:38:41 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省)]
    2024-10-22 13de4a3em68暂无昵称 来自浙江省

    需要倒查

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2256531, encodeId=1a40225653102, content=引起重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83098321849, createdName=ms9000001546471374, createdTime=Tue Mar 18 00:35:38 CST 2025, time=昨天, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2252280, encodeId=569d22522800d, content=可怕, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220814/be36b1918b4c4eeba48ae6c167571ce9/3bd4e17f256d4fdba54abc66bb0f616c.jpg, createdBy=a4042044999, createdName=jiangwei200908, createdTime=Mon Feb 17 08:51:28 CST 2025, time=2025-02-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2248460, encodeId=20082248460d9, content=追责堵漏防再发生！给岀解决方案, beContent=null, objectType=article, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220616/51508ed9a34741d2a61370b3293bb4f7/7f66d05e01f147f381a95f877e2de076.jpg, createdBy=58a75313391, createdName=13895086385H一, createdTime=Fri Jan 17 10:02:18 CST 2025, time=2025-01-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244256, encodeId=bde8224425600, content=谁的责任，这怎么分啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d545434460, createdName=美其美, createdTime=Sun Dec 22 06:41:40 CST 2024, time=2024-12-22, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2243556, encodeId=ad022243556f7, content=谁的责任？不？, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Thu Dec 19 17:53:49 CST 2024, time=2024-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2242646, encodeId=8c85224264644, content=后果已经造成，现在要做的就是尽快决定解决方案。, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=231c9560749, createdName=ms7000002062633164, createdTime=Sun Dec 15 16:09:57 CST 2024, time=2024-12-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233677, encodeId=941822336e759, content=我认为主要责任在血液中心, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e4d9506295, createdName=诗合晴岚, createdTime=Mon Oct 28 14:53:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2232588, encodeId=2057223258805, content=哪里出的问题？, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Wed Oct 23 08:25:10 CST 2024, time=2024-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232451, encodeId=e40722324512b, content=需要倒查, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 14:25:26 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2232323, encodeId=1d3022323231a, content=仔细查一下是谁的责任, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e994226832, createdName=13de4a3em68暂无昵称, createdTime=Tue Oct 22 07:38:41 CST 2024, time=2024-10-22, status=1, ipAttribution=浙江省)]
    2024-10-22 13de4a3em68暂无昵称 来自浙江省

    仔细查一下是谁的责任

    0

以上为热门评论，梅斯医学App还有更多内容

相关资讯

Pan Afr Med J ：2017-2018年莫桑比克艾滋病毒耐药性监测系统评估

2019年，全球约67%的艾滋病毒感染者接受了抗逆转录病毒治疗，其中26%开始治疗的人感染了对一线药物(如依法韦仑)耐药的病毒。

The Lancet Regional Health-Western Pacific：艾滋病毒自我检测工具包以促进艾滋病毒检测

在线分发M的HIVST试剂盒，并因PrEP项目完成而导致PrEP停止，这有效地促进了艾滋病毒检测。这种数字方法改善了MSM的艾滋病毒检测，并可以适用于MSM转向在线公共卫生服务的其他环境。

Lancet HIV：美国肛门癌患者按性别和艾滋病毒状况划分的存活率

艾滋病毒与肛门癌患者，特别是女性的全因死亡率有关。女性艾滋病毒患者的肛门癌特异性死亡率升高。随着肛门癌筛查越来越普遍，通过艾滋病毒状况和性别来检查筛查对生存的影响至关重要。

J Acquir Immune Defic Syndr：女性性工作者中艾滋病毒的流行率、发病率和风险因素

在全球范围内，2019年有170万人新感染艾滋病毒，比2020年UNAIDS目标高出三倍多。

Lancet HIV：联合预防策略对英国男同性恋和双性恋男性艾滋病毒发病率的影响

组合预防，包括PrEP战略，在迄今为止英国GBMSM中观察到的艾滋病毒发病率的减少方面发挥了重要作用。

Lancet Glob Health：注射吸毒者中艾滋病毒和丙型肝炎感染检测和治疗

注射吸毒者的艾滋病毒和HCV检测和治疗接受率差异很大，在大多数国家都不太理想。迫切需要制定战略，改善注射吸毒者获得艾滋病毒和丙型肝炎病毒护理的机会，并提供公共卫生监测。